Request Demo
Last update 25 Oct 2025
GSK-2241658A
Last update 25 Oct 2025
Overview
Basic Info
Drug Type Shared antigen vaccine, Therapeutic vaccine, Genetically engineered subunit vaccine |
Synonyms GSK 2241658A Antigen-Specific Cancer Immunotherapeutic, GSK Biologicals' 2241658A Antigen-Specific Cancer Immunotherapeutic, NY-ESO-1 Antigen Specific Cancer Immunotherapeutic + [7] |
Target |
Action modulators |
Mechanism NY-ESO-1 modulators(Cancer/testis antigen 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Login to view timeline
Related
1
Clinical Trials associated with GSK-2241658ANCT01213472
Study of GSK2241658A Antigen-Specific Cancer Immunotherapeutic in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma
100 Clinical Results associated with GSK-2241658A
Login to view more data
100 Translational Medicine associated with GSK-2241658A
Login to view more data
100 Patents (Medical) associated with GSK-2241658A
Login to view more data
100 Deals associated with GSK-2241658A
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic melanoma | Phase 1 | Australia | 31 Jan 2011 | |
| Metastatic melanoma | Phase 1 | Austria | 31 Jan 2011 | |
| Metastatic melanoma | Phase 1 | France | 31 Jan 2011 | |
| Metastatic melanoma | Phase 1 | Germany | 31 Jan 2011 | |
| Metastatic melanoma | Phase 1 | Italy | 31 Jan 2011 | |
| Metastatic melanoma | Phase 1 | Netherlands | 31 Jan 2011 | |
| Metastatic melanoma | Phase 1 | Switzerland | 31 Jan 2011 | |
| Metastatic melanoma | Phase 1 | United Kingdom | 31 Jan 2011 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 33 | awgrlpzdci = cufkwjaanw sepkwdxlmm (sdqxawwjfo, wljemibnsj - egrpwtgfhd) View more | - | 09 Oct 2019 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free